Variant report
Variant | esv3437872 |
---|---|
Chromosome Location | chr21:46478024-46479322 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr21:46473847..46475592-chr21:46476375..46478066,2 | MCF-7 | breast: |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-C21orf67-5 | chr21:46478093-46478164 | XLOC_014122 |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs185323268 | chr21:46478057-46478058 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs79478447 | chr21:46478067-46478068 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs149111370 | chr21:46478078-46478079 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs190033337 | chr21:46478103-46478104 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
5 | rs566848417 | chr21:46478118-46478119 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
6 | rs182251112 | chr21:46478138-46478139 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
7 | rs370396783 | chr21:46478185-46478186 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs73382614 | chr21:46478233-46478234 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs552535421 | chr21:46478245-46478246 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs143160218 | chr21:46478369-46478370 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs187290968 | chr21:46478425-46478426 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs538005946 | chr21:46478440-46478441 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs573266574 | chr21:46478525-46478526 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs200100591 | chr21:46478529-46478530 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs113501678 | chr21:46478530-46478531 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs201682632 | chr21:46478533-46478534 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs374779414 | chr21:46478684-46478685 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs111886341 | chr21:46478685-46478686 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs574951155 | chr21:46478706-46478707 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs535886639 | chr21:46478727-46478728 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs554187020 | chr21:46478752-46478753 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs568809498 | chr21:46478753-46478754 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs540512368 | chr21:46478758-46478759 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs372502123 | chr21:46478859-46478860 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs571163562 | chr21:46478860-46478861 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs375380752 | chr21:46478964-46478965 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs111961334 | chr21:46478965-46478966 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs147838157 | chr21:46478997-46478998 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs533884373 | chr21:46479032-46479033 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
30 | rs143854813 | chr21:46479033-46479034 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
31 | rs541467999 | chr21:46479082-46479083 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
32 | rs77373347 | chr21:46479127-46479128 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
33 | rs374817829 | chr21:46479172-46479173 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
34 | rs552837027 | chr21:46479174-46479175 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
35 | rs150410088 | chr21:46479239-46479240 | Weak transcription ZNF genes & repeats Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
36 | rs73382618 | chr21:46479286-46479287 | Weak transcription ZNF genes & repeats Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 16751803 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Down syndrome | 17412756 | CNVD |
Down syndrome | 17576883 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Seminomas | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Prostate cancer | 19156837 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Melanoma | 18172304 | CNVD |
Autism | 22958593 | CNVD |
Schizophrenia | 22958593 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Wilms tumour | 21544195 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Mental retardation | 21031080 | CNVD |
Polymicrogyria | 21031080 | CNVD |
periventricular nodular heterotopia | 21031080 | CNVD |
Myelodysplastic syndrome | 21606161 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Autism | 18414403 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Breast cancer | 21858162 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Breast cancer | 17899364 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Prostate cancer | 20473283 | CNVD |
Chordoma | 18071362 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Non-syndromic sensorineural hearing loss | 17457615 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Acute myeloid leukemia | 21358987 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Prostate cancer | 23341502 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Cholangiocarcinoma | 16830362 | CNVD |
Down syndrome | 17334655 | CNVD |
Neuroticism | 17667963 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Autoimmune polyendocrine syndrome | 18200029 | CNVD |
Prostate cancer | 19363497 | CNVD |
Lung cancer | 17086460 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Salivary gland adenoid cystic carcinoma | 17545515 | CNVD |
Multiple myeloma | 16616336 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Breast cancer | 21509527 | CNVD |
Breast cancer | 17142309 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 17426248 | CNVD |
Developmental delay | 21147756 | CNVD |
Breast cancer | 21364760 | CNVD |
Schizophrenia | 23813976 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr21:46471600-46484200 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
2 | chr21:46471800-46480200 | Weak transcription | Lung | lung |
3 | chr21:46475200-46478200 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
4 | chr21:46475200-46493400 | Weak transcription | Right Atrium | heart |
5 | chr21:46475400-46493200 | Weak transcription | Spleen | Spleen |
6 | chr21:46476400-46479200 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
7 | chr21:46476600-46480400 | Weak transcription | Fetal Lung | lung |
8 | chr21:46477200-46478200 | Weak transcription | Right Ventricle | heart |
9 | chr21:46477800-46478400 | Enhancers | Fetal Brain Male | brain |
10 | chr21:46478000-46478200 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
11 | chr21:46478200-46484000 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
12 | chr21:46479000-46479400 | Bivalent Enhancer | Fetal Muscle Trunk | muscle |
13 | chr21:46479200-46479400 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |